About J-GLOBAL

日本語

Font size
  • A
  • A

Articleの詳細情報

ArticleJ-GLOBAL ID:200902165204840750整理番号:00A0233351

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.

健康ボランティアにおけるアンギオテンシン変換酵素及び中性エンドペプチダーゼの二重阻害薬MDL‐100,240の反復経口投与のバイオアベイラビリティ

著者:ROUSSO P(Centre Hospitalier Univ. Vaudois, Lausanne, CHE)、BUCLIN T(Centre Hospitalier Univ. Vaudois, Lausanne, CHE)、NUSSBERGER J(Centre Hospitalier Univ. Vaudois, Lausanne, CHE)・・・
資料名:Eur J Clin Pharmacol 巻:55 号:10 ページ:749-754
発行年:2000年01月
  • J-GLOBAL home
  • Bookmark J-GLOBAL

J-GLOBAL: Linking, Expanding and Sparking

About J-GLOBAL

Linking

J-GLOBAL links information that represents the key to research and development. For example, linking articles and patents with people (authors and inventors) enables the extraction of a sequence of information.
It’s useful for making new discoveries and uncovering new information.

Expanding

The system enables searches of similar kinds of content through linkage with external sites.
It helps you to obtain knowledge from dissimilar fields and discover concepts that cross the boundaries of specialisms.

Sparking

Through repeated linkage and expansioniteration, J-GLOBAL provides unexpected hints for problem-solving and the illumination of new ideas.